Experience
Innovacell Biotechnologie AG
University of Pittsburgh
Represented Innovacell in opposition related to the use of myoblasts for treating stress urinary incontinence.
Innovacell Biotechnologie AG v. University of Pittsburgh, T 1050/12, EPO
*Matter handled prior to joining Finnegan
Innovacell Biotechnologie AG v. University of Pittsburgh*
Innovacell Biotechnologie AG
Innovacell AG v. University of Pittsburgh*
Innovacell AG
Finnegan client BTG prevails in EPO opposition proceedings in the field of vein sclerotherapy
BTG International, Ltd.
Abbott
GlaxoSmithKline
Hyundai Electronics v. Siemens AG
Hyundai Electronics
SAP AG
Omega Patents, LLC v. Bayerische Motoren Werke AG and BMW of North America, LLC
Bayerische Motoren Werke AG and BMW of North America, LLC
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.